511 related articles for article (PubMed ID: 15220403)
61. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
[TBL] [Abstract][Full Text] [Related]
62. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro.
Ziegelbauer J; Grundhoff A; Ganem D
J Virol; 2006 Mar; 80(6):2958-67. PubMed ID: 16501105
[TBL] [Abstract][Full Text] [Related]
63. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
64. Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex.
Roupelieva M; Griffiths SJ; Kremmer E; Meisterernst M; Viejo-Borbolla A; Schulz T; Haas J
J Gen Virol; 2010 May; 91(Pt 5):1138-49. PubMed ID: 20089804
[TBL] [Abstract][Full Text] [Related]
65. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
66. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
[TBL] [Abstract][Full Text] [Related]
67. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.
Park J; Lee MS; Yoo SM; Jeong KW; Lee D; Choe J; Seo T
J Virol; 2007 Nov; 81(22):12680-4. PubMed ID: 17855527
[TBL] [Abstract][Full Text] [Related]
68. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.
Krithivas A; Fujimuro M; Weidner M; Young DB; Hayward SD
J Virol; 2002 Nov; 76(22):11596-604. PubMed ID: 12388720
[TBL] [Abstract][Full Text] [Related]
69. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.
Stedman W; Deng Z; Lu F; Lieberman PM
J Virol; 2004 Nov; 78(22):12566-75. PubMed ID: 15507644
[TBL] [Abstract][Full Text] [Related]
70. Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.
Brown HJ; McBride WH; Zack JA; Sun R
Antivir Ther; 2005; 10(6):745-51. PubMed ID: 16218174
[TBL] [Abstract][Full Text] [Related]
71. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
72. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM
J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628
[TBL] [Abstract][Full Text] [Related]
73. Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.
Vázquez Ede L; Carey VJ; Kaye KM
J Virol; 2013 Nov; 87(22):12270-83. PubMed ID: 24006437
[TBL] [Abstract][Full Text] [Related]
74. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
75.
Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
[TBL] [Abstract][Full Text] [Related]
76. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
77. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
78. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
79. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions.
Mattsson K; Kiss C; Platt GM; Simpson GR; Kashuba E; Klein G; Schulz TF; Szekely L
J Gen Virol; 2002 Jan; 83(Pt 1):179-188. PubMed ID: 11752715
[TBL] [Abstract][Full Text] [Related]
80. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
